Skip to main content
Caplight Logo









Neuranix

Neuranix

Private
NaplesHealthcare & Life Scienceshttps://neuranix.com/

Last Round

VC Round

Jun 1, 2022

Total Funding Raised

$650,000

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Neuranix is a diagnostic equipment company that develops and produces diagnostic devices for pathologies of the middle ear for both human and veterinary use.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

middle ear diagnosticsdiagnostic deviceacoustic immittancePLAIpressureless acoustic immittancemedtechnon-invasive diagnosticstympanometry alternativeveterinary diagnosticshandheld medical devicevet techpediatric audiologyENT diagnosticsmedical hardwareAI diagnostics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Neuranix Comparables

Compare Neuranix with similar companies based on industry and business-model similarity.

Neuranix comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
OtoNexus Medical Technologies Inc.
81%
PhotoniCare
79%
Natus Medical Incorporated
74%

Neuranix Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJun 1, 2022
SeedAug 1, 2020

Key People

Founding team and executive leadership

Filip M.

Founder, CEO & Chairman of the board

Founding Team

Matteo Manente

Chief Technology Officer

Executive Team

Neuranix Investors

Notable investors and investment history

Neuranix investors
InvestorRounds
Bios Line HoldingVC Round
European Regional Development FundGrant
CDP Venture Capital SGRSeed
Kolind A/SVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 24, 2026

    Monthly visitors increased 41% MoM.

  • Jan 21, 2026

    Monthly visitors grew 267% MoM.

Neuranix Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Neuranix Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Neuranix's valuation, stock price, and market status.

Firmographic Details

HeadquartersNaples
Employee Range12
Year Founded2017
Last FundingJun 1, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?